Ectopic production of 1,25-dihydroxyvitamin D in high-grade intranasal non-intestinal-type adenocarcinoma induced hypercalcemic crisis: a case report with review of literature
Endocrine Journal · 2025
DOI: 10.1507/endocrj.ej25-0038 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endocrine Journal, 2025. Verfasst von Muneo Kawasumi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima 731-0293, Japan. Hauptthemen laut MEDLINE: Adenocarcinoma, Hypercalcemia, Vitamin D, Nose Neoplasms. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hypercalcemia is an oncologic metabolic emergency in cancer patients, primarily caused by local osteolytic hypercalcemia and humoral hypercalcemia of malignancy. Hormones associated with oncologic metabolic emergency include parathyroid hormone and parathyroid hormone-related peptide (PTHrP), but 1,25-dihydroxyvitamin D (1,25(OH)2D) is rarely the cause. We report the case of an 87-year-old man with hypercalcemic crisis owing to 1,25(OH)2D overproduction from a high-grade intranasal non-intestinal-type adenocarcinoma. 1,25(OH)2D and corrected Ca levels normalized after tumor resection and did not re-elevate subsequently. Serum PTH was suppressed and PTHrP not detected, suggesting the hypercalcemia was not due to the PTH pathway. Immunohistochemistry for CYP27B1, a key enzyme that converts 25-hydroxyvitamin D (25(OH)D) to 1,25(OH)2D, showed positivity in the cytosol of about 20% of tumor cells, but only about 1% of the macrophages. On the other hand, CYP24A1, a 1,25(OH)2D-degrading enzyme, was diffusely expressed in the cytosol of about 80% of tumor cells. These findings may suggest overproduction of CYP27B1 mRNA. The balance between synthesis and degradation of 1,25(OH)2D in tumor tissue is thought to be implicated in the development of 1,25(OH)2D-producing solid tumors. Further case accumulation and studies will be needed to confirm this hypothesis. Nonetheless, in diagnosing 1,25(OH)2D-producing solid tumors, it is important to evaluate not only CYP27B1 expression but also CYP24A1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Diabetology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima 731-0293, Japan.
- Department of Endocrinology and Diabetology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan.
- Department of Otorhinolaryngology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan.
- Department of Diagnostic Pathology, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima 737-0023, Japan.
Zitieren
APA
Kawasumi, M., Kubota, M., Furuie, H., & Kuraoka, K. (2025). Ectopic production of 1,25-dihydroxyvitamin D in high-grade intranasal non-intestinal-type adenocarcinoma induced hypercalcemic crisis: a case report with review of literature. Endocrine Journal. https://doi.org/10.1507/endocrj.ej25-0038
Vancouver
Kawasumi M, Kubota M, Furuie H, Kuraoka K. Ectopic production of 1,25-dihydroxyvitamin D in high-grade intranasal non-intestinal-type adenocarcinoma induced hypercalcemic crisis: a case report with review of literature. Endocrine Journal. 2025. doi:10.1507/endocrj.ej25-0038
BibTeX
@article{Kawasumi2025,
author = {Kawasumi, Muneo and Kubota, Mitsunobu and Furuie, Hiromi and Kuraoka, Kazuya},
title = {Ectopic production of 1,25-dihydroxyvitamin D in high-grade intranasal non-intestinal-type adenocarcinoma induced hypercalcemic crisis: a case report with review of literature},
journal = {Endocrine Journal},
year = {2025},
doi = {10.1507/endocrj.ej25-0038}
}
EUVIMED